cd147-car t cells
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 27, 2019 (NCT03993743)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- BasiginImmunity, passive
BSG immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05013372 | Early Phase 1 (Phase 1) | Oct 31, 2021 | Peking University |
| NCT04045847 | Early Phase 1 (Phase 1) | May 30, 2019 | Xijing Hospital |
| NCT03993743 | Phase 1 | May 27, 2019 | Xijing Hospital |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Xijing Hospital | Academic/Hospital | 2 | 2 | 1 | 2019 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1